MFA Financial, Inc.
NYSE:MFAREIT - Mortgage
+$0.13 today
- Market cap
- $585.08M
- Beta
- 1.50
- P/E (TTM)
- 7.3
- EPS (TTM)
- $1.30
- Dividend yield
- 15.14%
Volume 3.92M
Average 1.42M
MFA Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
MFA Financial, Inc.NYSE: MFA
Research & Development · Q1 FY2026 · quarter ended Mar 2026
Research & development remains negative
Q1 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $200K.
Context
- Research & development amounted to 0.0% of revenue in FY2025, down 0.3 pp from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $50K.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 0 USD
- Year-over-year change
- -100.0%
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | -100.0% |
| FY2024 | 2024-12-31 | 800K | +0.0% |
| FY2023 | 2023-12-31 | 800K | +0.0% |
| FY2022 | 2022-12-31 | 800K | +100.0% |
| FY2021 | 2021-12-31 | 400K | — |
Research & Development vs competitors
How MFA compares with its peers on the latest reported figures
- MFA's LTM Mar 2026 research & development of $200K is the highest of the 8 companies compared; the peer median is $0.
- Its year-over-year change of +0.0% is the highest of 2, against a peer median of -100.0%.
- Research & development amounts to 0.0% of revenue for MFA, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $200K | +0.0% | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | -100.0% | +0.2% | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding MFA) | $0 | -100.0% | +0.2% | 0.0% | |
Competitors are the stored peer set for MFA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 337.22M | (67.62M) | 234.05M | 279.61M | 875.24M |
| Cost of Revenue | 37.47M | 42.89M | 34.14M | 35.31M | 33.45M |
| Gross Profit | 299.75M | (110.52M) | 199.91M | 244.3M | 841.79M |
| Gross Margin | 88.9% | 163.4% | 85.4% | 87.4% | 96.2% |
| Research & Development | 400K | 800K | 800K | 800K | 0 |
| Selling, General & Admin | 85.55M | 112.72M | 129.95M | 131.91M | 41.74M |
| Operating Expenses | (8.35M) | 113.52M | 130.75M | 132.71M | 151.76M |
| Depreciation & Amortization | 61.91M | 9.2M | 4.2M | 3.2M | 2.2M |
| EBITDA | 433.02M | 0 | 0 | 0 | 690.03M |
| EBITDA Margin | 128.4% | 0.0% | 0.0% | 0.0% | 78.8% |
| Operating Income | 328.87M | (224.03M) | 69.16M | 111.59M | 690.03M |
| Operating Margin | 97.5% | 331.3% | 29.6% | 39.9% | 78.8% |
| Interest Income | 362.3M | 482.42M | 605.6M | 723.97M | 745.06M |
| Interest Expense | 120.39M | 258.84M | 429.12M | 521.23M | 513.98M |
| Other Income / Expenses | (6.2M) | (8.4M) | 11M | 8.1M | (513.98M) |
| Income Before Tax | 328.87M | (232.43M) | 80.16M | 119.69M | 176.05M |
| Pre-Tax Margin | 97.5% | 343.7% | 34.3% | 42.8% | 20.1% |
| Income Tax Expense | 0 | (851K) | 0 | 443K | (735K) |
| Net Income | 328.87M | (231.58M) | 80.16M | 119.25M | 176.78M |
| Net Margin | 97.5% | 342.5% | 34.3% | 42.6% | 20.2% |
| EPS (Basic) | 2.66 | (2.40) | 0.46 | 0.83 | 1.71 |
| EPS (Diluted) | 2.63 | (2.40) | 0.46 | 0.82 | 1.68 |
| Weighted Avg Shares | 110.7M | 103.15M | 102.22M | 103.49M | 103.68M |
| Weighted Avg Shares (Diluted) | 118.47M | 103.15M | 103.58M | 105.1M | 105.31M |
MFA Financial, Inc.
NYSE:MFA
Intrinsic Alpha fair value
Locked
Current Price
$5.79
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.